Stocks / NASDAQ / Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals, Inc.

Our Opinion

Tetraphase Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing some of their therapeutic procedures and clinical research.

Supporting Evidence:

Report that specifies that the company conducts animal testing

” ERV is being evaluated for the use in the therapeutic treatment of tularemia, plague and anthrax in animal models”

Company Description

Tetraphase Pharmaceuticals, Inc. (Tetraphase), incorporated on July 7, 2006, is a clinical-stage biopharmaceutical company. The Company uses its chemistry technology to create antibiotics for multidrug-resistant infections. The Company is developing its lead product candidate, eravacycline, a fully synthetic tetracycline derivative, as a spectrum intravenous (IV) and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant Gram-negative infections. The Company also develops TP-6076 for multidrug-resistant Gram- negative infections. [Source: Reuters]

Company Website: https://www.tphase.com